Re your positive comment, Ben.
"The ongoing exemplary safety profile of Imugene's immunotherapy products has enabled Imugene to obtain approvals for trials ahead of time, as noted with the company's recent approval to conduct a clinical trial for their Oncarlytics treatment arm in conjunction with Blincyto"President Biden’s 2016 pledge for faster U.S, approval for cancer drug cocktails
Biden pledges faster U.S. approval for cancer drug cocktails | Reuters
Will the threat of the possible return ofDonald Trump to challenge him at the next Presidential Election sharpen PresidentBiden’s commitment?
Re your positive comment, Ben."The ongoing exemplary safety...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
-0.001(1.30%) |
Mkt cap ! $570.9M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.5¢ | $1.862M | 24.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 3727016 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 129670 | 4 |
View Market Depth
| Last trade - 13.38pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
-0.001 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.5¢ | 12563142 | ||
| Last updated 13.56pm 07/05/2024 ? | |||||
| IMU (ASX) Chart |